<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item><item key="factor_count">0</item><item key="sample_count">6</item><item key="tags"><item>cancer</item><item>chromatin</item><item>genome</item></item><item key="slug">identification-of-sp1-targets-involved-in-prolifer</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-37935</item><item key="id">2424</item><item key="species">human</item><item key="name">Identification of Sp1 targets involved in proliferation and cancer</item></item><item><item key="factor_count">0</item><item key="sample_count">9</item><item key="tags"><item>breast</item><item>breast cancer</item><item>cancer</item><item>cell</item><item>disease</item><item>estrogen</item><item>genome</item><item>hormone</item><item>line</item><item>median</item><item>nucleotide</item><item>protein</item></item><item key="slug">identification-of-the-receptor-tyrosine-kinase-axl</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-21832</item><item key="id">3659</item><item key="species">human</item><item key="name">Identification of the receptor tyrosine kinase AXL in triple negative breast cancer as a novel target for the human miR-34a microRNA (gene expression)</item></item><item><item key="factor_count">1</item><item key="sample_count">12</item><item key="tags"><item>cerebrospinal fluid</item><item>cytokine</item><item>disease</item><item>genome</item><item>line</item><item>multiple sclerosis</item><item>rrms</item><item>serum</item></item><item key="slug">ifnb-1a-in-vivo-treatment-induces-the-expression-a</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-53716</item><item key="id">2033</item><item key="species">human</item><item key="name">IFNb-1a in-vivo treatment induces the expression and signaling of IFNAR1 and inhibits Th17 responses in PBMCs derived from CIS patients</item></item><item><item key="factor_count">3</item><item key="sample_count">13</item><item key="tags"><item>atherosclerosis</item><item>cell</item><item>cell adhesion molecule</item><item>chromatin</item><item>deep</item><item>disease</item><item>endothelial cell</item><item>endothelium</item><item>genome</item><item>interleukin</item><item>monocyte</item><item>vascular disease</item></item><item key="slug">il-4-mediated-gene-expression-profiles-in-vascular</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-28117</item><item key="id">4006</item><item key="species">human</item><item key="name">IL-4 mediated gene expression profiles in vascular endothelial cells</item></item><item><item key="factor_count">2</item><item key="sample_count">27</item><item key="tags"><item>bone</item><item>bone marrow</item><item>cell</item><item>chronic myeloid leukemia</item><item>class</item><item>genome</item><item>hematopoietic system</item><item>leukemia</item><item>myeloid leukemia</item></item><item key="slug">imatinib-therapy-of-chronic-myeloid-leukemia-resto</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-33075</item><item key="id">2166</item><item key="species">human</item><item key="name">Imatinib therapy of chronic myeloid leukemia restores the expression levels of key genes for DNA damage and cell cycle progression</item></item><item><item key="factor_count">11</item><item key="sample_count">50</item><item key="tags"><item>actin</item><item>actin cytoskeleton</item><item>cytoskeleton</item><item>genome</item><item>glucose</item><item>insulin</item><item>muscle</item><item>serum</item></item><item key="slug">increased-srf-transcriptional-activity-is-a-novel</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-25462</item><item key="id">3873</item><item key="species">human</item><item key="name">Increased SRF Transcriptional Activity is a Novel Signature of Insulin Resistance in Humans and Mice</item></item><item><item key="factor_count">1</item><item key="sample_count">7</item><item key="tags"><item>genome</item></item><item key="slug">inducible-expression-of-myod-directly-mediates-myo</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-46633</item><item key="id">2145</item><item key="species">human</item><item key="name">Inducible expression of MyoD directly mediates myogenic conversion of human induced pluripotent stem cells (iPSCs) derived from Duchenne muscular dystrophy (DMD).</item></item><item><item key="factor_count">3</item><item key="sample_count">59</item><item key="tags"><item>genome</item><item>muscle</item><item>protein</item><item>skeletal muscle tissue</item></item><item key="slug">inferring-drug-induced-gene-regulatory-relationshi</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-29868</item><item key="id">4129</item><item key="species">human</item><item key="name">Inferring drug-induced gene regulatory relationships in primary human hepatocytes</item></item><item><item key="factor_count">2</item><item key="sample_count">24</item><item key="tags"><item>cancer</item><item>cell</item><item>genome</item><item>prostate</item><item>prostate cancer</item></item><item key="slug">inhibition-of-bet-bromodomain-proteins-as-a-therap</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-56352</item><item key="id">2080</item><item key="species">human</item><item key="name">Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer</item></item><item><item key="factor_count">1</item><item key="sample_count">64</item><item key="tags"><item>cell</item><item>genome</item><item>inferior</item><item>lymphoma</item><item>mantle cell lymphoma</item></item><item key="slug">integrated-genomic-profiling-in-mantle-cell-lympho</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-21452</item><item key="id">3639</item><item key="species">human</item><item key="name">Integrated genomic profiling in mantle cell lymphoma</item></item></data></biogps>
